دورية أكاديمية

Impact of Hemoglobin Levels on Composite Cardiac Arrest or Stroke Outcome in Patients With Respiratory Failure Due to COVID-19.

التفاصيل البيبلوغرافية
العنوان: Impact of Hemoglobin Levels on Composite Cardiac Arrest or Stroke Outcome in Patients With Respiratory Failure Due to COVID-19.
المؤلفون: Feng SN; Division of Neuroscience Critical Care, Departments of Neurology, Neurosurgery, and Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD., Kelly TL; School of Public Health and Social Work, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia., Fraser JF; Critical Care Research Group, Faculty of Medicine, Queensland University of Technology, Brisbane, QLD, Australia.; Adult Intensive Care Services, The Prince Charles Hospital, Brisbane, QLD, Australia., Li Bassi G; Critical Care Research Group, Faculty of Medicine, Queensland University of Technology, Brisbane, QLD, Australia.; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain., Suen J; Critical Care Research Group, Faculty of Medicine, Queensland University of Technology, Brisbane, QLD, Australia., Zaaqoq A; Department of Critical Care Medicine, MedStar Washington Hospital Center, Georgetown University, Washington, DC., Griffee MJ; Department of Anesthesiology, University of Utah School of Medicine, Salt Lake City, UT., Arora RC; Harrington Heart and Vascular Institute, University Hospitals, Cleveland, OH.; Department of Surgery, Case Western Reserve University, Cleveland, OH., White N; School of Public Health and Social Work, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia.; Critical Care Research Group, Faculty of Medicine, Queensland University of Technology, Brisbane, QLD, Australia., Whitman G; Division of Neuroscience Critical Care, Departments of Neurology, Neurosurgery, and Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD., Robba C; School of Public Health and Social Work, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia., Battaglini D; School of Public Health and Social Work, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia., Cho SM; Division of Neuroscience Critical Care, Departments of Neurology, Neurosurgery, and Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
مؤلفون مشاركون: COVID-19 Critical Care Consortium (CCCC)
المصدر: Critical care explorations [Crit Care Explor] 2024 Aug 22; Vol. 6 (9), pp. e1143. Date of Electronic Publication: 2024 Aug 22 (Print Publication: 2024).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 101746347 Publication Model: eCollection Cited Medium: Internet ISSN: 2639-8028 (Electronic) Linking ISSN: 26398028 NLM ISO Abbreviation: Crit Care Explor Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Philadelphia, PA : Wolters Kluwer Health, [2019]-
مواضيع طبية MeSH: COVID-19*/complications , COVID-19*/epidemiology , COVID-19*/blood , Heart Arrest*/epidemiology , Heart Arrest*/etiology , Hemoglobins*/analysis , Hemoglobins*/metabolism , Anemia*/epidemiology , Anemia*/blood , Respiratory Insufficiency*/epidemiology , Respiratory Insufficiency*/etiology , Stroke*/epidemiology , Stroke*/blood, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Aged ; Intensive Care Units ; SARS-CoV-2 ; Registries ; Risk Factors ; Adult
مستخلص: Objectives: Anemia has been associated with an increased risk of both cardiac arrest and stroke, frequent complications of COVID-19. The effect of hemoglobin level at ICU admission on a composite outcome of cardiac arrest or stroke in an international cohort of COVID-19 patients was investigated.
Design: Retrospective analysis of prospectively collected database.
Setting: A registry of COVID-19 patients admitted to ICUs at over 370 international sites was reviewed for patients diagnosed with cardiac arrest or stroke up to 30 days after ICU admission. Anemia was defined as: normal (hemoglobin ≥ 12.0 g/dL for women, ≥ 13.5 g/dL for men), mild (hemoglobin 10.0-11.9 g/dL for women, 10.0-13.4 g/dL for men), moderate (hemoglobin ≥ 8.0 and < 10.0 g/dL for women and men), and severe (hemoglobin < 8.0 g/dL for women and men).
Patients: Patients older than 18 years with acute COVID-19 infection in the ICU.
Interventions: None.
Measurements and Main Results: Of 6926 patients (median age = 59 yr, male = 65%), 760 patients (11.0%) experienced stroke (2.0%) and/or cardiac arrest (9.4%). Cardiac arrest or stroke was more common in patients with low hemoglobin, occurring in 12.8% of patients with normal hemoglobin, 13.3% of patients with mild anemia, and 16.7% of patients with moderate/severe anemia. Time to stroke or cardiac arrest by anemia status was analyzed using Cox proportional hazards regression with death as a competing risk. Covariates selected through clinical knowledge were age, sex, comorbidities (diabetes, hypertension, obesity, and cardiac or neurologic conditions), pandemic era, country income, mechanical ventilation, and extracorporeal membrane oxygenation. Moderate/severe anemia was associated with a higher risk of cardiac arrest or stroke (hazard ratio, 1.32; 95% CI, 1.05-1.67).
Conclusions: In an international registry of ICU patients with COVID-19, moderate/severe anemia was associated with increased hazard of cardiac arrest or stroke.
Competing Interests: Drs. Suen, Li Bassi, and Fraser received support for article research from the Bill and Melinda Gates Foundation. Drs. Fraser’s, Suen’s, and Li Bassi’s institutions received funding from The Bill and Melinda Gates Foundation. Dr. Suen is funded by the Advance Queensland fellowship program, Queensland Government, Australia. Dr. Li Bassi’s institution received funding from Fisher & Paykel. Dr. Li Bassi is a recipient of the Biomedical international training research programme for excellent clinician-scientists (BITRECS) fellowship; the “BITRECS” project has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement no. 754550 and from the “La Caixa” Foundation (ID 100010434), under the agreement LCF/PR/GN18/50310006. Dr. Cho received funding from Hyperfine. Dr. Arora has received honoraria from Edwards Lifesciences, HLS Therapeutics, and Bioporto as well is on the advisory board for Renibus Therapeutics for work unrelated to this article. The remaining authors have disclosed that they do not have any potential conflicts of interest.
(Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.)
References: Gardner WM, Razo C, McHugh TA, et al.: Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: Findings from the Global Burden of Disease Study 2021. Lancet Haematol 2023; 10:e713–e734.
Xu T, Liang D, Wu S, et al.: Association of hemoglobin with incidence of in-hospital cardiac arrest in patients with acute coronary syndrome complicated by cardiogenic shock. J Int Med Res 2019; 47:4151–4162.
Kim IJ, Yang PS, Kim TH, et al.: Relationship between anemia and the risk of sudden cardiac arrest—a nationwide cohort study in South Korea. Circ J Off J Jpn Circ Soc 2018; 82:2962–2969.
Heo J, Youk TM, Seo KD: Anemia is a risk factor for the development of ischemic stroke and post-stroke mortality. J Clin Med 2021; 10:2556.
Chen HF, Ho TF, Kuo YH, et al.: Association between anemia severity and ischemic stroke incidence: A retrospective cohort study. Int J Environ Res Public Health 2023; 20:3849.
Gupta A, Madhavan MV, Sehgal K, et al.: Extrapulmonary manifestations of COVID-19. Nat Med 2020; 26:1017–1032.
Hayek SS, Brenner SK, Azam TU, et al.; STOP-COVID Investigators: In-hospital cardiac arrest in critically ill patients with Covid-19: Multicenter cohort study. BMJ 2020; 371:m3513.
Nannoni S, de Groot R, Bell S, et al.: Stroke in COVID-19: A systematic review and meta-analysis. Int J Stroke 2021; 16:137–149.
Merkler AE, Parikh NS, Mir S, et al.: Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza. JAMA Neurol 2020; 77:1366–1372.
Algassim AA, Elghazaly AA, Alnahdi AS, et al.: Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection. Ann Hematol 2021; 100:37–43.
Sarcia N, Thai D, Bodine A: Hemoglobin as a predictor for COVID-19 disease severity. Adv Clin Med Res Healthc Deliv 2022; 2:9.
Li Bassi G, Suen J, Barnett AG, et al.; COVID-19 Critical Care Consortium Investigators: Design and rationale of the COVID-19 Critical Care Consortium international, multicentre, observational study. BMJ Open 2020; 10:e041417.
von Elm E, Altman DG, Egger M, et al.: Strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. BMJ 2007; 335:806–808.
Harris PA, Taylor R, Thielke R, et al.: Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42:377–381.
World Bank Data Help Desk: World Bank Country and Lending Groups. 2024. Available at: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups. Accessed January 24, 2024.
Knaus WA, Draper EA, Wagner DP, et al.: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818–829.
Vincent JL, Moreno R, Takala J, et al.: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707–710.
Badireddy M, Baradhi KM: Chronic anemia. In: StatPearls. Treasure Island, FL, StatPearls Publishing, 2024, pp 1.
American Society of Hematology: Anemia. 2024. Available at: https://www.hematology.org/education/patients/anemia. Accessed January 15, 2024.
Cho SM, Premraj L, Fanning J, et al.: Ischemic and hemorrhagic stroke among critically ill patients with coronavirus disease 2019: An international multicenter coronavirus disease 2019 critical care consortium study. Crit Care Med 2021; 49:e1223–e1233.
Yaddanapudi LN: The American Statistical Association statement on P-values explained. J Anaesthesiol Clin Pharmacol 2016; 32:421–423.
Leacy FP, Floyd S, Yates TA, et al.: Analyses of sensitivity to the missing-at-random assumption using multiple imputation with delta adjustment: Application to a tuberculosis/HIV prevalence survey with incomplete HIV-status data. Am J Epidemiol 2017; 185:304–315.
Yuan Y: Multiple Imputation for Missing Data. 2005. Available at: https://stats.oarc.ucla.edu/wp-content/uploads/2016/02/multipleimputation.pdf. Accessed August 19, 2024.
Fan BE, Chong VCL, Chan SSW, et al.: Hematologic parameters in patients with COVID-19 infection. Am J Hematol 2020; 95:E131–E134.
Tang N, Bai H, Chen X, et al.: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020; 18:1094–1099.
Lazarian G, Quinquenel A, Bellal M, et al.: Autoimmune haemolytic anaemia associated with COVID-19 infection. Br J Haematol 2020; 190:29–31.
Bharmal M, DiGrande K, Patel A, et al.: Impact of coronavirus disease 2019 pandemic on cardiac arrest and emergency care. Heart Fail Clin 2023; 19:231–240.
Robba C, Battaglini D, Ball L, et al.: Coagulative disorders in critically ill COVID-19 patients with acute distress respiratory syndrome: A critical review. J Clin Med 2021; 10:140.
Kause J, Smith G, Prytherch D, et al.; Intensive Care Society (UK); Australian and New Zealand Intensive Care Society Clinical Trials Group: A comparison of antecedents to cardiac arrests, deaths and emergency intensive care admissions in Australia and New Zealand, and the United Kingdom—the ACADEMIA study. Resuscitation 2004; 62:275–282.
Chang JY, Lee JS, Kim BJ, et al.: Influence of hemoglobin concentration on stroke recurrence and composite vascular events. Stroke 2020; 51:1309–1312.
Abou-Ismail MY, Diamond A, Kapoor S, et al.: The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thromb Res 2020; 194:101–115.
Kuno T, So M, Takahashi M, et al.: U shape association of hemoglobin level with in-hospital mortality for COVID-19 patients. J Thromb Thrombolysis 2022; 53:113–117.
Rawal G, Kumar R, Yadav S, et al.: Anemia in intensive care: A review of current concepts. J Crit Care Med 2016; 2:109–114.
Xie Y, Xu E, Bowe B, et al.: Long-term cardiovascular outcomes of COVID-19. Nat Med 2022; 28:583–590.
Eberhardt N, Noval MG, Kaur R, et al.: SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels. Nat Cardiovasc Res 2023; 2:899–916.
المشرفين على المادة: 0 (Hemoglobins)
تواريخ الأحداث: Date Created: 20240822 Date Completed: 20240822 Latest Revision: 20240822
رمز التحديث: 20240823
DOI: 10.1097/CCE.0000000000001143
PMID: 39172625
قاعدة البيانات: MEDLINE
الوصف
تدمد:2639-8028
DOI:10.1097/CCE.0000000000001143